WeRide (WRD US) Buy: 1Q26 broadly in line; fleet ramp intact

Research evidence excerpt

WeRide (WRD US) Buy: 1Q26 broadly in line; fleet ramp intact

Equities ● Auto Components

14 May 2026

Potential share price catalysts

1. Potential Hong Kong Stock Connect inclusion (early June 2026 window).

2. Broader regulatory support, particularly cross-district and city-level commercial operations

in Tier-1 cities and overseas, especially in the Middle East and Europe.

3. Fleet deployment acceleration and improving unit economics through 2026.

4. 2Q26 earnings update: more disclosure on commercialisation progress.

Key downside risks

1. Regulatory timing risk

Advances in technology and supply chains may outpace regulatory easing. If approvals lag

expectations or tighten temporarily following safety incidents, stock volatility could increase.

That said, while regulatory paths may fluctuate, we believe the strategic direction remains

towards normalisation and institutionalisation of robotaxi operations.

2. Competitive structure risk

The structural risk to pure-play robotaxi operators is not marginal technical

underperformance, but the entry of L3-scalers (OEMs and Tier-1 suppliers) with

manufacturing scale and capital advantages. Their participation could compress the time

window for standalone operators to establish density and operational moats. Additionally, if

WeRide allocates disproportionate resources to overseas expansion while falling behind in

domestic fleet scaling, its competitive position in China could weaken.

3. Overseas policy and execution risk

Overseas markets, particularly the Middle East, carry higher policy and operational

uncertainty. Although markets such as Abu Dhabi are making rapid progress in licensing

robotaxis, if the pace is slower than expected due to regional political instability, WeRide’s

overseas first-mover advantage could erode.